Amyloid ,!?/A4 protein precursor (APP) is secreted into medium by most cultured cells and can function as an autocrine factor. To study the biological function of secreted forms of APP (sAPP) on neurons, we used a clonal CNS neuronal line, B103, which does not synthesize detectable levels of APP. 8103 cells transfected with APP construct developed neurites faster than the parent B103 cells when plated in a serum-free defined medium. Neurite outgrowth of 8103 cells was promoted by the conditioned medium of APP-695-overproducing cells or by the bacteria-produced sAPP-695 (named KB75). A series of peptides having sequences between Ala-31 9 and Met-335 of APP-695 also stimulated neurite outgrowth of 8103 cells. The sequence of five amino acids, RERMS , within this stretch of sequence, was the shortest active peptide, although the concentration required for the neuritotropic activity was higher than that of KB75. Binding assay using ia51-labeled APP 17-mer peptide corresponding to Ala-319 to Met-335 of APP-695 as a ligand demonstrated specific and saturable cellsurface binding sites. The predicted K, value was 20 f 5 nM and the B,,,,, value was 60 + 6 fmol/lOg cells. The binding could be displaced with KB75. A 17-mer peptide with reverse sequence neither induced neurite outgrowth nor competed for the binding. A bacteria-produced sAPP fragment lacking the active 17-mer sequence (named KB756) did not compete with 12Wabeled
17-mer for binding or stimulate neurite extension. A peptide of sequence RMSQ , which partially overlaps the active sequence RERMS, could block the neuritotropic effects of both KB75 and the 17-mer at higher concentrations.
APP 17-mer was also found to induce the accumulation of inositol polyphosphates, suggesting that the APP 17-mer effects involve activation of inositol phospholipid signal transduction systems. These data indicate that sAPP induces neurite extension through cell-surface binding and that the domain containing the RERMS sequence (APP 326-332) represents the active site responsible for this function.
Amyloid PIA4 protein (A/3), a major component of both the plaque and vascular amyloid in the brain tissue of patients afflicted with Alzheimer's disease (AD) (Glenner and Wong, 1984; Masters et al., 1985; Selkoe et al., 1986) , is a peptide of about 4.2 kDa produced by cleavage of a large precursor molecule, amyloid /?/A4 protein precursor (APP) (Goldgaber et al., 1987; Kang et al., 1987; Robakis et al., 1987; Tanzi et al., 1987 ). There are three major isoforms of APP resulting from differential splicing of a primary RNA transcript. APP-695 shares the same amino acid sequence with APP-751 and APP-770 except that it does not contain a domain showing a strong homology with Kunitz-type protease inhibitors (KPI) (Kitaguchi et al., 1988; Ponte et al., 1988; Tanzi et al., 1988) . APPs with and without the KPI domain are secreted into the growth-conditioned medium (CM) of cultured cells (Schubert et al., 1988 Refolo et al., 1989; Weidemann et al., 1989) . The secretory pathway involves a proteolytic cleavage either at /3 16 within A@ (Esch et al., 1990; Sisodia et al., 1990; Anderson et al., 1991; Wang et al., 199 1) or at the amino terminus of A/3 (Seubert et al., 1993) , releasing the long N-terminal fragment (secreted APP, sAPP) into the medium. sAPPs are also found in plasma and cerebrospinal fluid (Selkoe et al., 1988; Ghiso et al., 1989; Palmert et al., 1989a ,b, Podlisny et al., 1990 Prior et al., 1991; Van Nostrand et al., 1992) suggesting a biological significance in viva Consistent with this idea, purified sAPPs were shown to have trophic activities on cultured fibroblasts Bhasin et al., 199 l) , cortical neuronal cells (Araki et al., 199 l) , and PC12 cells (Milward et al., 1992) , and to protect culture neurons from hypoglycemia-induced cytotoxicity (Mattson et al., 1993) . N-terminal epitopes of APP were also found in the neurites of neuritic plaques (Arai et al., 1990; Cole et al., 199 1; Cras et al., 1991; Joachim et al., 1991; Shoji et al., 1991; Cummings et al., 1992; Masliah et al., 1992a,b) and growing axons (Masliah et al., 1992c) , suggesting that APP may play a role in neuritic sprouting in the brain. On the other hand, membranebound APP has a receptor-like architecture (Kang et al., 1987) , with a region in the cytoplasmic domain capable of complexing with GTP-binding protein (Nishimoto et al., 1993) . We have previously identified a small stretch of the sAPP sequence as the active site in the regulation of fibroblast growth (Roth et al., 1992; Ninomiya et al., 1993) . In the present study, we asked whether this sequence of APP was also active on neuronal cells in terms of neurite extension. A, Several clones of neuronal cell lines were compared for the amount of APP secreted; 3.5 x 105 cells were plated onto 100 mm tissue culture dishes in 3.5 ml of serum-free medium and cultured for 18 hr. Medium was then harvested and spun at -500 x g for 5 min, and supernatant was passed through a 0.45 pm pore filter and desalted using a Sephadex G50 column. Ten micrograms of medium protein were electrophoresed on 7.5% polyacrylamide gels containing SDS, transferred to nitrocellulose, and immunostained with anti-GID, an antibody against APP residues 175-l 86 . The cells from which the CM was analyzed were as follows: lane I, PC12; lane 2, R33, a line from rat retina; lane 3, B35; lane 4, B50; lane 5, B65; lane 6, B103; and lane 7, B104. B35, B50, B65, B103, and B104 are clones of nerve cells derived from rat brain (Schubert et al., 1974) . The scale shows the molecular weight in kilodaltons. B, Total RNA was extracted from exponentially growing cells by the acid phenol method (Chomczynski and Sacchi, 1987) . Ten micrograms of total RNA were separated on a II agarose gel, transferred onto a nylon membrane, and hybridized with the 32P-labeled 1.1 kb EcoR 1 fragment of human APP cDNA. Lane I, RNA from B103; lane 2, RNA from PC12. The locations of 28 S and 18 S ribosomal RNA are indicated.
Materials and Methods
The APP peptides. APP peptides used in this study were synthesized using a Rainin PS3 peptide synthesizer and purified on a C-18 reversephase HPLC column. The peptides were purified in a gradient of acetonitrile. This solvent was eliminated by evaporation under vacuum, and the peptides were resolubilized in 50 mM NaHCO, (pH 7.4). Since C6 and C7 peptides were not soluble in this buffer, they were initially solubilized in a small amount of dimethyl sulfoxide (DMSO) and then diluted to give a final concentration of DMSO in the culture medium of less than 0. II. Preparation ofAPP-overproducing cells. The experimental conditions are reported elsewhere (Schubert and Behl, 1993) . Briefly, a fragment of human APP-695 cDNA including full coding sequence was subcloned into pORFex 13 (Bernard et al., 1987) , in which the expression of APP-695 was driven by cytomegalovirus promoter. Clonal B103 cells were then cotransfected with pSV-2neo and the APP expression plasmid using a standard calcium phosphate method. Stably transfected lines were selected with 400 &/ml G4 18 and cloned.
The neurite extension assay. B103 cell clones were maintained in DMEM supplemented with 10% FBS. For the experiments in serumfree condition, late exponentially dividing B 103 cells were washed twice with PBS, dissociated by gentle trituration in PBS, spun down, brought up in N2 medium (Bottenstein and Sato, 1979) , and plated at a density of 5 x 103/cm2.
Because fixation ofcells may change their morphology, for the purpose of accurate quantification cells were photographed under phase optics 20 or 30 hr after plating. Each experimental condition was either in triplicate (in a 24 well plate) or sextuplicate (in a 96 well plate) and was repeated at least twice. Routinely we photographed the central portion of each well with the best phase contrast, excluding the small number of fields containing unusual cell density or cell aggregates. Neurite numbers and lengths were quantified with the aid ofa morphometric program on a Quantimet. A neurite was defined as a cellular process longer than the longest diameter ofthe cell body. The sum ofeither neurite numbers or neurite lengths was then divided by the number of cells counted. At least 200 cells were counted in each experimental condition.
The APP binding assay. The 17-mer peptide was iodinated with 1251-Bolton-Hunter reagent (Amersham Co.; 2000 Ci/mmol, 500 pCi) according to the manufacturer's instructions. In brief, the peptide solution (10 wg in 10 ~1 of 0.1 M NaHCO, buffer, pH 8.5) was incubated with the dried reagent at 4°C overnight. The reaction was quenched with glycine (100 pl of 1 mg/ml solution in H,O) and the iodinated peptide was separated from the unincorporated reagent through Sephadex G15 column (1 cm2 x 25 cm) saturated with PBS containing 0.15% gelatin (PBSG). The specific activity of the 1251-17-mer thus obtained was 40-
The Journal of Neuroscience, September 1994, 14 (9) The replicate experiments gave essentially the same result. For the CM experiments, serum-free CM from 10 hr cultures of each cell line (5 x lO)/cm*) was transferred to a new plate of B103 culture so that the final concentration of CM was 50%. The absence and presence of APP in the CM of B103/neo/C13 and B103/695/C17, respectively, were confirmed by immunoblotting using several anti-APP antibodies. In a 20 hr period, B103/695/C17 grew more and longer neurites per cell compared to B103/neo/C13, and CM from B103/695/C17 induced more and longer neurites from B103 compared to that from B 103/neo/C13. Error bars indicate SEM throughout. Asterisks indicate significant differences relative to the effect of neo vector transfection control revealed by Student's t test (*, p i 0.05; **, p < 0.01). In testing the neurite extension effect of sAPP, we found no qualitative difference between neurite length measurement and neurite number measurement as an index of neurite extension. Therefore, only the neurite number measurement is demonstrated in the later experiments.
60 Wmmol. For the binding assays, B103 cells in the late log phase Znositol polyphosphates assay. B103 cells in the late log phase were were harvested in PBS, spun down at 1200 x g for 5 min, and resusharvested in PBS and resuspended in comnlete arowth medium with pended in Dulbecco's modified Eagle's medium (DMEM)/S% fetal bothe density of 1 x lo5 cells/ml. )H-inosiiol (Amersham, Arlington vine serum (FBS). The suspension (4 x lo5 cells/ml) was seeded in a Heights, IL) was then added to the cell suspension at 5-l 0 pCi/ml and 24-well plate (0.5 ml/well) and the plate was kept at 37°C in a CO, 0.25 ml of the suspension was plated into each well in a 24-well plate. incubator for 3 hr. The plate was then transferred on ice and the medium After incubation for 24 hr, the cells were washed once with Krebswas immediately replaced with ice-cold PBSG. After 30 min, the binding Hensleit buffer with LiCl (KHL buffer, composed of 100 mM NaCl, 4.7 reaction was started by replacing the PBSG with fresh, ice-cold PBSG mM KCl. 1.3 mM CaCl,. 1.2 mM KH,PO,. 1.2 mM MeSO,. 25 mM containing 125I-1 7-mer peptide and various competitor peptides as inNaHCO,, 11.7 mM glucose, and 20 rn& LiCl) previously eqcilibrated dicated. The reaction volume was 0.25 ml. After various lengths of with 5% CO,. APP peptides in 300 ~1 of KHL buffer were then added time, the binding media were aspirated and the cell layer was washed to each well and the cultures were incubated in the CO, incubator for three times with 0.5 ml of ice-cold PBSG. The radioactivity remaining 30 min. The incubations were terminated by adding 100 &well iceon the cell layer was then recovered in 0.5 ml of the extraction buffer (0.5% Triton X-100,0.1 M NaHCO,, pH 7.4) and counted in a gamma counter. All the binding assays were done in triplicate.
cold 10% perchloric acid, neutralized with KGH, andihe cellular debris was pelleted by centrifugation. The supernatants were applied to small columns containing Dowex anion-exchange resin AG 1 x8 ( 100-200 mesh, Bio-Rad, Hercules, CA) to separate total inositol phosphates from inositol. The columns were washed with water and 'H-inositol phosphates were eluted with 2 ml of 1 N HCl directly into scintillation vials containina 10 ml of scintillation cocktail (Ecolume, ICN Biomedicals, Irvine, CA). Adhesion assay. Exponentially dividing B 103 cells were metabolically labeled with 'H-leucine (5 &i/ml) for 15 hr. The cells were collected without using any trypsin or chelating agents, washed three times with HEPES-buffered DME containing 0.4% BSA, and resuspended in the same solution. Aliquots of 2 ml containing 1 x lo5 cells were pipetted into 35 mm petri dishes pretreated with and without the peptides. After incubation at 37°C for 30 min, the dishes were swirled 10 times, the medium was aspirated, the remaining attached cells were dissolved in 3% Triton X-100, and their isotope content was determined. To adsorb peptides to the dish surface, dishes covered by 0.5 ml of DME containing the peptides were incubated overnight at 37°C and then washed twice with DME and once with HEPES-buffered DME containing 0.4% BSA.
Results

B103 rat CNS neuronal cells do not synthesize or secrete APP
All cell lines with neuronal characteristics that we have screened so far secrete abundant APP into the media (Fig. 1 ) except for the cell line B103 (Schubert et al., 1974) . Because sAPP's action is probably through an autocrine mechanism in cell culture Araki et al., 1991; Bhasin et al., 1991; Milward et al., 1992 ) it would be difficult to demonstrate the effect of exogenously applied APP to cells actively secreting APP. Either the effect of applied APP would be masked or the APP-mediated mechanism would be downregulated or saturated by endogenous APP. Therefore, we employed B 103 cells for our experiments. In contrast to fibroblasts Bhasin et al., 1991) APP was not required for the growth of B103.
B103 cells transfected with APP expression plasmids extend more neurites
After transfection of B 103 cells with an APP expression plasmid construct, we selected several clonal B 103 lines with high levels of APP expression (Schubert and Behl, 1993) : B103/695 clones produced APP-695, whereas B103/Neo clones were controls transfected with the expression vector only. B 103/695 and B 103/ Neo did not differ in growth rate or in morphology when grown in serum-containing medium. To induce morphological differentiation of B103 cells (Schubert et al., 1974) , clones of transfected cells were cultured in N2 serum-free defined medium (Bottenstein and Sato, 1979) , and their morphology was compared. Figure 2 shows the morphology of a clone of B103/Neo and a clone of B103/695 cultured for 30 hr at equal density (5 x 1 O3 cells/cm2) in N2 medium on tissue culture plastic. While B103/Neo cells had begun to grow neurites, the B103/695 culture already had long neurites. Although we cultured cells for 30 hr in this experiment, we employed 20 hr culture conditions for later experiments with essentially the same results. Quantification of independent cultures at 20 hr after plating demonstrated that the average neurite number per cell (Fig. 2C ) and the neurite length (Fig. 20) were significantly increased in the B103/695 cells as compared to B 103/Neo cells. Furthermore, when CM from B103/695 cultures was placed on B103 cells, it induced neurite extension; CM from B 103/Neo cultures did not (Fig. 2C,D) . CM from other APP-695-overproducing B103 clones obtained from the same transfection also enhanced neu- The concentration of '*51-17-mer was 10 nM. Nonspecific binding was defined as the binding in the presence of 1 rnM unlabeled 17-mer. The numbers presented were calculated from the data shown in Figure S&F (Table 1) are presented in C.
Compared to the control, APP 1 I-mer and APP 17-mer induced more neurite extension per B103 cell (**, p < O.Ol), but R-17 and APP 8-mer did not have a significant effect on neurite extension. In D, effects of small peptides within APP 1 I-mer (Table 1) rite extension. These data suggested that secreted proteins, possibly sAPP-695, promoted the neurite extension.
sAPP produced in E. coli promotes neurite extension by B103 cells
To confirm the neurite extension activity of sAPP, however, a pure sAPP preparation was required. Using a prokaryotic expression system, we produced an APP polypeptide, KB75 (Val-20 to Ile-59 l), corresponding to sAPP-695, which does not contain the AD domain (Roth et al., 1992) . At concentrations from 10 to 100 nM, purified KB75 induced neurite extension in B 103 culture (Fig. 3, open The APP domain containing the RERMS sequence represents the active site for promotion of neurite extension by B103 cells As shown in Figure 4A , a synthetic peptide corresponding to Ala-319 to Met-335 of APP-695 (Kang et al., 1987 ) (APP 17-mer; see Table 1 for amino acid sequence) was also active in stimulating neurite extension of B 103 cells in a dose-dependent manner. A deletion mutant of KB75 (named KB756) that does not contain the active 17-mer domain (Ninomiya et al., 1993) did not show a significant effect on neurite extension (Fig. 4B ).
The 17-mer peptide neither increased cell number nor enhanced short-term cell-substratum adhesion (data not shown), in contrast to sAPP purified from CM . To show the sequence specificity, we tested the 17-mer peptide, an 8-mer peptide at the N-terminal of the 17-met-, an 11 -mer peptide at the C-terminal of the 17-mer, and a control peptide with sequence reversed from that of APP 17-mer (named R-17, Table  1 ). As shown in Figure 4C , at 40 nM, APP 17-mer and 1 I-mer peptides significantly promoted neurite extension when com- Table 1 . F, Same experiment as in D, except KB75 (0) or KB756 (0) was used to compete with 1251-17-mer binding.
pared to a control culture, but 8-mer and R-l 7 did not. To identify the minimum sequence requirement for the neurite extension activity of sAPP, we tested shorter peptides within the 11 -mer sequence. We found that a pentamer peptide, RERMS (M5), stimulated neurite extension, although only at a high concentration (Fig. 40) . The N-terminal or C-terminal portion of the 11 -mer peptide did not have any neurite-promoting activity (N5, N4, C7, and C6; see Table 1 , Fig. 40 ).
APP peptide binds to detergent-extractable site on B103 cells
Since the neurite extension activity of APP requires specific sequence, it may be mediated through cell-surface molecules interacting with that sequence. To test this possibility, binding assays were carried out using 17-mer peptide labeled with Bolton-Hunter reagent (called 12%1 7-mer) on a B103 cell monolayer. The detergent-extractable binding of 1251-17-mer to the (Fig. 5C ) (Scatchard et al., 1949) . This number corresponds to approximately 5 x lo4 binding sites per cell. The binding was sequence specific because 17-mer, but not R-17, could displace the binding, and the C-terminal 1 I-mer of the 17-mer displaced the binding, whereas N-terminal 8-mer did not (Fig. SD) . The inhibition study using various fragments of the 1 I-mer peptide (Fig. 5E ) suggested that the five-amino-acid sequence (RERMS) in the middle portion of the 1 I-mer peptide is important for the binding activity (Table 1) . The binding was displaced by ICE375 but not by ICE3756 (Fig. 5F ). Therefore, a domain containing the RERMS sequence in the secreted form of APP-695 is likely to be recognized by cell-surface molecules.
The peptide RMSQ antagonizes APP effect to promote neurite extension
As RERMS seems to be a critical sequence of sAPP-695 for both the cell-surface binding and biological activity, peptides with sequences that partially overlap RERMS and lack biological activity might compete for the binding site and antagonize the effect of active APP fragments. To test this possibility, we examined the RMSQ (APP 330-333) peptide that has been shown to block the APP activity in fibroblast growth assay (Ninomiya et al., 1993) . RMSQ at concentrations above 20 PM significantly blocked neutite extension from B103 cells treated with 40 nM of KB75 (Fig. 6) or 17-mer (data not shown). The RMSQ peptide at those concentrations had no obvious effect on B 103 cells by itself and was not cytotoxic. The blocking effect was sequence specific because APP 8-mer, which did not inhibit APP 17-mer binding, did not block the effect of APP 17-mer or Kl375, even at a lOOO-fold higher concentration (data not shown). This inhibition effect was reversible, since a higher concentration (100 nM) of KB75 overcame the antagonism of 20 MM RMSQ (Fig. 3, solid circles) . These data suggest that RMSQ blocks APP activity to promote neurite extension through competition for the same binding site. They also suggest that the RERMS domain of APP is the active site required for the neurite extension activity of this molecule, supporting the conclusion obtained with KB756.
APP binding induces phosphoinositide turnover Phosphoinositide (PI) turnover represents the transduction mechanism of some neurotransmitters and neurotrophic factors acting through surface receptors (Berridge and Irvine, 1989) . Because active APP peptides bind to neuronal surface molecules, we tested whether they also induce PI turnover. As shown in Figure 7 , at concentrations comparable to those effective for neurite extension and binding activity, KB75, 17-mer, and 1 lmer stimulated the accumulation of inositol polyphosphates. Inactive peptides 8-mer and R-17 did not stimulate the accumulation of inositol polyphosphates, indicating the sequence specificity of the effect.
APP peptide does not increase cell adhesion to substratum The rate of neurite outgrowth is partly determined by how tightly the cells adhere to the substratum. To determine whether the neurite induction by APP 17-mer is through the enhancement of adhesiveness, we measured the initial adherence rate of B103 cells plated into dishes coated with APP 17-mer. Figure 8 demonstrates that at concentrations equivalent to our neurite extension experiments, 17-mer that adhered to the dish surface did not enhance the initial adherence rate of B 103 cells, whereas under similar conditions poly-L-lysine and FBS did enhance the adhesion. On the other hand, we demonstrated previously that purified APP at the femtomole range enhanced the rapid adherence of PC12 cells to dishes . Thus, APP 17-mer does not represent a domain responsible for the adhesion-promoting effect of APP.
Discussion
We demonstrated that the secreted form of APP-695 promotes neurite extension of B103 cells. The neuritotropic activity of APP resides in the middle domain of APP containing RERMS, and is independent of the KPI (Robakis et al., 1990) or A@ (Whitson et al., 1989 (Whitson et al., , 1990 Yankner et al., 1990) domains that are reported to be neurotrophic. The neurite induction, cellsurface binding, and induction of inositol polyphosphate accumulation all require the same amino acid sequence and a similar concentration range. Although RERMS seems to be the most important sequence in APP for its neuritotropic activity, the surrounding amino acids also contribute to binding and biological activity, since RERMS's neuritotropic activity is orders of magnitude less than that of KB75 and the 17-mer peptide. Nevertheless, the requirement of the specific sequence for net&e-extending activity suggests the presence of a potential APP receptor. This is further suggested by the identification of a competitive peptide antagonist, RMSQ. The presence of approximately 50,000 APP binding sites per cell that are extractable by nonionic detergent also argues for the presence of an APP receptor on the cell surface.
There are two plausible mechanisms for APP to promote neurite extension, one through membrane receptor activation and the other through a mechanism that increases cell adhesiveness to the substratum, although these two mechanisms are not mutually exclusive. Our binding study demonstrated that the APP recombinant proteins or peptides bound specifically to detergent-extractable cell-surface molecules, but did not bind specifically to the substratum. The specific binding was dependent on the presence of cells: the culture dish had only nonsaturable and nonreplaceable binding. Furthermore, we observed comparable APP binding (-50,000 sites/cell, -20 nM KD) in cell suspension assays or in assays with purified membrane fractions (data not shown). Although APP 17-mer peptide adsorbed to the culture dish did not promote cell adhesion to the substratum (Fig. 8 ) APP preadsorbed to the culture dish did promote cell adhesion to the substratum . This APP effect on cell adhesion may be related to its activity to bind heparan sulfate proteoglycan (Narindrasorasak et al., 1991; Small et al., 1992 Small et al., , 1993 Buee et al., 1993; Ninomiya et al., 1994) , collagen (Breen, 1992) or laminin (Narindrasorasak et al., 1992; Kibbey et al., 1993) . We investigated several conditions to diminish the nonspecific binding of the APP recombinant proteins and peptides to substratum. We found that BSA actually increased the nonspecific APP binding to substratum. This is why we used gelatin in our binding assay to decrease the nonspecific binding. The inclusion of these proteins in the assay medium did not alter the efficacy of the APP 17-mer peptide to promote neurite extension. As the 17-mer APP peptide does not stimulate cell substratum adhesion, it is not likely that the 17-mer peptide promotes neurite outgrowth by increasing cell adhesion. Instead, its activity is probably through cell-surface binding and possibly through a receptor-mediated mechanism. However, despite data that suggest the presence of APP receptors, it is extremely difficult to exclude the possibility that the biological function ofthe APP recombinant protein and peptides is through substratum binding and not through receptor binding. The final conclusion as to the mechanisms of APP function might be drawn when the putative APP receptor is cloned and the receptor "knock out" experiments are carried out. Milward et al. (1992) demonstrated that either soluble or membrane-associated APP purified from human brain had a neurite-promoting effect on PC12 at a concentration of lo-lo M. The neurite outgrowth effect of APP observed by Milward et al. (1992) may be through modulation of cell adhesion , or it may be due to the receptor-mediated mechanism we propose in this report. In their culture system, APP was added to 24 hr subcultures of PC1 2 in serum-containing medium. Thus it is probable that extracellular matrix (ECM) and endogenous APP had been deposited onto the substratum. The complex interaction of added APP with endogenous APP, ECM components (Klier et al., 1990; Small et al., 1992 Small et al., , 1993 and serum proteins cannot be neglected. In the present B103 culture system, we did not have interference from serum proteins and endogenous APP. We also eliminated the possible interaction with ECM components by adding APP at the time of cell plating. Furthermore, APP 17-mer does not bind heparan sulfate proteoglycan or ECM (Ninomiya et al., 1993) . The possible contaminating activity besides that of sAPP in the purified protein samples Araki et al., 199 1; Bhasin et al., 1991; Milward et al., 1992) was also avoided in our experiments by using synthetic peptides. In addition, our active APP peptides do not contain a cell adhesion-promoting sequence attributed to AD (Breen et al., 199 1; Ghiso et al., 1992; Koo et al., 1993) , and they did not promote cell-substratum adhesion (Fig. 8) .
Further confirmation of the biological significance of neurite extension activity of APP requires the demonstration of the presence of the active APP fragment and the receptor in the normal neuronal environment and the effect in viva The presence of the N-terminal portion of APP in cerebrospinal fluid indicates that it is probably secreted and available in the brain. Additionally, APP is physiologically released from rat hippocampal slices (Nitsch et al., 1993) . APP undergoes fast anterograde axonal transport , and may be secreted into the synaptic cleft. The neurite extension activity of sAPP reported here and by others (Araki et al., 199 1; Milward et al., 1992) may be involved in the maintenance of synaptic integrity, as previously suggested (Schubert, 199 1; Price et al., 1992) .
